By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Acrux Limited 

103-113 Stanley Street

West Melbourne  Victoria  3003  Australia
Phone: 61-3-8379-0100 Fax: 61-3-8379-0101



Company News
Acrux (ACR) Plunges After Deal With Eli Lilly (LLY) Is Terminated 9/6/2017 5:45:59 AM
Eli Lilly and Company (LLY) Pays Acrux Limited $87M on FDA Approval of Testosterone Replacement Therapy 11/24/2010 6:33:21 AM
Eli Lilly and Company (LLY) (JOBS) Gets Rights to Sell Testosterone Drug from Acrux Limited in Deal Worth up to $335 Million 3/16/2010 6:58:43 AM
Acrux Limited Announces Successful AXIRON Phase III Trial Results; Trial Met Primary Endpoint 9/29/2009 7:03:14 AM
KV Pharmaceutical Company (KV-A) Signs Expanded Worldwide Partnership With Acrux Limited, Including the Development of Six New Branded Products 8/12/2008 6:35:47 AM
Acrux Limited Completes $22.5 Million Capital Raising 7/18/2007 12:29:08 PM
Acrux Limited to Push on with Phase 3 Testosterone Trial 7/18/2007 12:24:05 PM
Acrux Limited Announces Positive Clinical Trial Results with Combination Contraceptive Sprays 7/3/2007 1:00:19 PM
Acrux Limited and Organon (AKZOY) to Develop Contraceptive Sprays 3/1/2007 12:14:53 PM
Acrux Limited To Start USA Trial Of Its Unique Testosterone Lotion For Men 9/18/2006 12:50:56 PM